首页> 外文期刊>Cancer: A Journal of the American Cancer Society >Updated American Cancer Society HPV Vaccine Guideline Seeks to Reinforce Key Messages New recommendations emphasize the importance of routinely offering the vaccine at the ages of 9 to 12 years

【24h】

Updated American Cancer Society HPV Vaccine Guideline Seeks to Reinforce Key Messages New recommendations emphasize the importance of routinely offering the vaccine at the ages of 9 to 12 years

机译：更新的美国癌症社会HPV疫苗指南旨在加强关键信息新建议强调常规向9至12年内提供疫苗的重要性

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Cancer: A Journal of the American Cancer Society》 |2021年第8期|共2页
作者
Printz Carrie;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献

1. Safety and immunogenicity of a 9-valent HPV vaccine in females 12-26 years of age who previously received the quadrivalent HPV vaccine [J] . Garland Suzanne M., Cheung Tak-Hong, McNeill Shelly, Vaccine . 2015,第48期

机译：9价HPV疫苗在先前接受四价HPV疫苗的12-26岁女性中的安全性和免疫原性
2. Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18-45 years [J] . EinsteinM.H., BaronM., LevinM.J., Human vaccines . 2011,第12期

机译：人乳头瘤病毒（HPV）-16/18疫苗和HPV-6 / 11/16/18疫苗对18-45岁健康女性非致癌型HPV-31和HPV-45疫苗的免疫原性比较
3. Summary of the National Advisory Committee on Immunization's Updated Recommendations on Human Papillomavirus (HPV) vaccines: Nine-valent HPV vaccine and clarification of minimum intervals between doses in the HPV immunization schedule [J] . Summary of the National Advisory Committee on Immunization’s Updated Recommendations on Human Papillomavirus (HPV) vaccines: Nine?valent HPV vaccine, clarification of minimum intervals between doses in the HPV immunization schedule Tunis MC Footnote 1, Deeks SL Footnote 2, Canada communicable disease report =: Relev?des maladies transmissibles au Canada . 2016,第4期

机译：全国免疫咨询委员会关于人乳头瘤病毒（HPV）疫苗的最新建议的摘要：九价HPV疫苗，并阐明了HPV免疫时间表中的最小剂量间隔
4. Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine administered according to 2- and 3-dose schedules in girls aged 9–14 years: Results to month 12 from a randomized trial [O] . Ting Fan Leung, Anthony Pak-Yin Liu, Fong Seng Lim, 2015

机译：在9至14岁女孩中按2和3剂量方案施用人乳头瘤病毒（HPV）-16/18 AS04辅助疫苗和HPV-6 / 11/16/18疫苗的比较免疫原性和安全性：每月的结果来自随机试验的12
5. Human Papillomavirus vaccination in general practice in France, three years after the implementation of a targeted vaccine recommendation based on age and sexual history : Targeted HPV vaccine recommendation in France [O] . Thierry, Pascale, Lasserre, Andrea, Rossignol, Louise, 2015

机译：在实施基于年龄和性病史的针对性疫苗建议后的三年中，法国进行了人乳头瘤病毒疫苗的常规接种：法国针对性HPV疫苗建议

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号